Hepatitis

Advancements in the pipeline for hepatitis C eradication

Lack of rapid testing and payer restrictions are creating barriers, experts say

And a look at the bigger picture behind the frozen-food outbreaks

Persistent viral suppression in most patients, even after 8 years

Pilot trial demonstrates that FMT can boost gut health, prevent serious infections

Phase IIb ENLIVEN trial saw success with various doses of pegozafermin

Public health expert describes pivot to provide medical aid in war-torn Ukraine

At 48 weeks, bulevirtide led to undetectable HDV RNA, normalization of ALT in up to 48%

Investigational drug more likely to resolve severe form of fatty liver disease, improve fibrosis

Intervention reduced infections, but not mortality; no improvement on other endpoints

Risk 40% lower with use among those with preexisting liver disease, study found

Goal of 30% reduction in serum creatinine in the absence of full response or HRS reversal

While study suggests treatment initiation did not differ by race, editorial expresses doubt

In small study of children with severe hepatitis, 93% of blood samples tested positive for AAV2